Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Drug discovery technology pioneered at Oncogene Science now patented

Sep. 12, 1997

Preliminary results reported for RMP-7/carboplatin

Sep. 9, 1997

Roche subscribes to Easy Access for Affymetrix GeneChip

Sep. 8, 1997

Breakthrough discovery in receptor function reported by Acadia

Sep. 8, 1997

Roche terminates antisense collaboration with Hybridon

Sep. 8, 1997

ICOS and Abbott expand collaboration

Sep. 4, 1997

Injectable drug delivery systems based on biodegradable block copolymers

Sep. 3, 1997

Strakan exercises option to develop Access drug delivery technology

Sep. 3, 1997

Quadrant licenses platelet technology to Pall

Sep. 2, 1997

InSite obtains license for retinal drug delivery technology

Aug. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...